Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes (Q44599736)
Jump to navigation
Jump to search
scientific article published on October 1, 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes |
scientific article published on October 1, 2003 |
Statements
1 reference
Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes (English)
1 reference
Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes (English)
1 reference
Josephine M Egan
1 reference
Joel F Habener
1 reference
Nigel Greig
1 reference
Hugh Tildesley
1 reference
Dariush Elahi
1 reference
Graydon S. Meneilly
1 October 2003
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference